Interferon and interferon inhibitor levels in patients infected with varicella-zoster virus, acquired immunodeficiency syndrome, acquired immunodeficiency syndrome-related complex, or Kaposi's sarcoma, and in normal individuals.

The American Journal of Medicine
J L AmbrusK C Chadha

Abstract

Previous studies had reported that normal individuals do not have measurable levels of interferons in their circulation, whereas high levels have been found in patients in the early stages of AIDS (acquired immunodeficiency syndrome) and in those with AIDS-related complex (ARC). This study was undertaken to compare levels of interferon and interferon inhibitors in plasma samples from patients with AIDS, ARC, Kaposi's sarcoma, or varicella-zoster virus infection, and from control subjects. A total of 206 persons were tested for the presence of interferon and interferon inhibitors in their plasma: 76 with ARC or AIDS, with or without Kaposi's sarcoma or lymphoma; 32 with varicella-zoster infection; 12 with AIDS-unrelated Kaposi's sarcoma; and 86 normal control subjects at high or low risk of AIDS with or without positive antibody levels to human immunodeficiency virus-1. Total interferon activity was measured by bioassay and the subtypes were not separated. Of 86 normal control subjects, 85 had no significant levels of interferon or interferon inhibitor. One disease-free homosexual exhibited measurable interferon levels. Patients acutely infected with varicella-zoster virus showed no measurable interferon or inhibitor levels exce...Continue Reading

References

Sep 1, 1988·The New England Journal of Medicine·J L AmbrusK C Chadha

❮ Previous
Next ❯

Citations

May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·D ZaguryR C Gallo
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·R C Gallo
Jul 5, 2001·Proceedings of the National Academy of Sciences of the United States of America·D ZaguryR C Gallo
Oct 25, 2002·DNA and Cell Biology·R C GalloD Zagury
May 25, 1999·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·B BizziniA Gringeri
May 3, 2007·PLoS Medicine·Ulrich E Schaible, Stefan H E Kaufmann
Nov 7, 2013·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Jennifer C DonnellyFionnuala Ní Ainle
Sep 10, 2003·Antiviral Chemistry & Chemotherapy·K Kedzierska, S M Crowe
Jan 1, 1994·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·A Lachgar, B Bizzini
Dec 14, 1999·The Journal of Laboratory and Clinical Medicine·F Romerio, R C Gallo
Sep 1, 1996·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·A GringeriD Zagury
Mar 30, 1999·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·A GringeriD Zagury
Jan 1, 1991·Current Eye Research·J S Pepose
Jun 1, 2004·Experimental Biology and Medicine·Julian L Ambrus, Julian L Ambrus
Mar 27, 2004·Experimental Biology and Medicine·Kailash C ChadhaJulian L Ambrus
Sep 1, 1994·Annals of Clinical Biochemistry·S G Ball

❮ Previous
Next ❯

Related Concepts

Related Feeds

AIDS Malignancies (ASM)

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.